| Application no. and date | 19720693.1 (espacenet) (Federated) (European Patent Register), 20190506 | | Patent/reg. no. and date | DK/EP 3790575, 20250730 | | Publication date | 20210317 | | Priority no. and date | EP 18171046, 20180507 | | EP pub. no. and date |
EP 3790575 20210317 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | VEGGE, Andreas, Novo Allé, 2880 Bagsværd, DK,
BJERREGAARD, Simon, Novo Allé, 2880 Bagsværd, DK,
LYTT, RAHBEK, Ulrik, Novo Allè, 2880 Bagsværd, DK,
JONAS, SASSENE, Philip, Novo Allè, 2880 Bagsværd, DK,
JEROEN, WATER, Jorrit, Novo Allè, 2880 Bagsværd, DK | | Representative | | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61P 3/04 (2006.01) , A61P 3/10 (2006.01) | | Title | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | | Int. application no. | EP2019061502 | | Int. publication no. | WO2019215063 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
